Mylan Inc (NASDAQ:MYL)

CAPS Rating: 5 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Results 1 - 20 of 110 : 1 2 3 4 5 6 Next »

Recs

0
Member Avatar AllTooFoolish (79.93) Submitted: 4/5/2016 4:17:33 PM : Outperform Start Price: $45.92 MYL Score: -10.17

Benchmark Investing math has this stock about 27% below its Downside price. It should do nicely over the next few years.

Recs

0
Member Avatar Ikarruss (33.22) Submitted: 3/2/2016 11:15:39 AM : Outperform Start Price: $45.45 MYL Score: -12.35

Good ratios, good product, in a good market. I think this stock will out preform the US market.

Recs

0
Member Avatar PearlandTX (52.46) Submitted: 2/11/2016 11:25:24 AM : Outperform Start Price: $40.97 MYL Score: -11.79

Pure speculation

Recs

0
Member Avatar 1russianguy (46.23) Submitted: 1/19/2016 12:36:52 PM : Outperform Start Price: $50.25 MYL Score: -26.72

SBD2016

Recs

0
Member Avatar Sparticus501 (< 20) Submitted: 1/4/2016 11:01:10 AM : Outperform Start Price: $53.38 MYL Score: -25.65

Long-term, this is a winner. Drug patents run out, then this company profits. With drug prices skyrocketing, the market will have to turn to generic drugs and Mylan will profit.

Recs

1
Member Avatar graybell (< 20) Submitted: 10/23/2015 1:46:29 PM : Outperform Start Price: $41.13 MYL Score: +1.92

OVERSOLD

Recs

1
Member Avatar ruinas (54.40) Submitted: 9/25/2015 3:08:21 PM : Outperform Start Price: $42.86 MYL Score: -10.18

continued improving earnings as patents expired for big pharma

Recs

1
Member Avatar boywonder88 (60.60) Submitted: 9/25/2015 1:58:10 PM : Outperform Start Price: $44.25 MYL Score: -11.77

generic drug is the way to go for common illnesses and aging population. The revenue growth in this industry should continue to have a healthy rise. The only question is the cost control for MYL

Recs

0
Member Avatar Bobmoll36 (38.65) Submitted: 9/23/2015 3:27:55 PM : Outperform Start Price: $45.40 MYL Score: -14.82

Follow the fool

Recs

0
Member Avatar CMFmdriver78 (42.74) Submitted: 9/10/2015 11:48:08 AM : Outperform Start Price: $44.59 MYL Score: -13.96

Stock Advisor - 8/15

Recs

0
Member Avatar motto1628 (< 20) Submitted: 8/23/2015 3:02:05 PM : Outperform Start Price: $47.88 MYL Score: -22.94

go generics!

Recs

0
Member Avatar benyboy (< 20) Submitted: 3/5/2015 9:24:49 AM : Outperform Start Price: $56.26 MYL Score: -23.83

John Paulson

Recs

0
Member Avatar mrudolph72 (55.64) Submitted: 3/3/2015 6:43:05 PM : Outperform Start Price: $55.79 MYL Score: -23.30

Eddie from CWS explains why 4 years ago Mylan was a bargain hidden in plain site. Let's see if it still is.

5 year hold

http://www.crossingwallstreet.com/archives/2015/03/mylans-earnings.html

Recs

0
Member Avatar TerryHoodSr (62.85) Submitted: 6/14/2014 10:04:52 AM : Outperform Start Price: $50.06 MYL Score: -23.10

SOLID LONGTERM BUY@50 TP 60

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 2/19/2014 4:50:54 PM : Underperform Start Price: $50.98 MYL Score: +30.77

Demark 13 weekly sell

Recs

0
Member Avatar BELLEXP (< 20) Submitted: 1/26/2014 7:17:58 AM : Outperform Start Price: $44.20 MYL Score: -20.86

EARNINGS OF NEW DRUGS COMING OFF PATENT

Recs

0
Member Avatar Zee (< 20) Submitted: 12/28/2013 8:05:01 PM : Outperform Start Price: $42.77 MYL Score: -14.69

strength in the emerging biotech market of biosimilars

Recs

0
Member Avatar DrLinks (< 20) Submitted: 7/24/2013 2:12:24 AM : Outperform Start Price: $32.32 MYL Score: +7.53

Mylan is a STRON generic s well as Proprietary drug maker!

Recs

0
Member Avatar BillZack (< 20) Submitted: 4/14/2013 1:23:36 PM : Underperform Start Price: $28.64 MYL Score: -15.05

Bearish head and shoulders pattern, too far too fast.

Recs

0
Member Avatar 10cent (97.30) Submitted: 3/21/2013 11:57:24 PM : Outperform Start Price: $30.34 MYL Score: +4.23

generic xanax

Results 1 - 20 of 110 : 1 2 3 4 5 6 Next »

Featured Broker Partners